Table 2 Multivariable adjusting Cox regression analysis to determine risk covariates for aortic dissection and aneurysm.
Characteristics | Aortic dissection and aneurysm | |
|---|---|---|
aHR (95% CI)* | P-value | |
FQs exposure vs. non-FQs exposure | 1.61 (1.45–1.78) | < 0.001 |
Age group, years | ||
< 40 (reference) | 1 | < 0.001 |
40–55 | 2.21 (1.55–3.14) | |
≥ 55 | 9.39 (6.83–12.92) | |
Male vs. female | 2.47 (2.23–2.74) | < 0.001 |
Comorbidities | ||
Hypertension | 1.14 (1.02–1.28) | 0.023 |
Hyperlipidemia | 0.97 (0.89–1.07) | 0.565 |
Hyperparathyroidism | 0.84 (0.37–1.88) | 0.669 |
Diabetes mellitus | 0.75 (0.68–0.83) | < 0.001 |
Hepatobiliary disorders | 0.75 (0.57–0.97) | 0.031 |
Kidney disease | 0.93 (0.73–1.17) | 0.508 |
Cerebrovascular disease | 1.30 (1.16–1.45) | < 0.001 |
Ischemic stroke | 1.12 (0.95–1.31) | 0.183 |
Chronic obstructive pulmonary disease | 1.06 (0.96–1.17) | 0.252 |
Coronary artery disease | 1.50 (1.16–1.93) | 0.001 |
Asthma | 0.88 (0.79–0.97) | 0.014 |
Genital tract infection | 1.03 (0.93–1.13) | 0.608 |
Soft tissue and bone infection | 0.90 (0.82–0.98) | 0.015 |
Lower respiratory tract infection | 0.97 (0.88–1.07) | 0.532 |
Septicemia | 1.36 (1.20–1.54) | < 0.001 |
Seizure | 0.50 (0.25–1.01) | 0.052 |
Medications | ||
ACEI/ARB | 1.40 (1.24–1.58) | < 0.001 |
Beta-blockers | 1.36 (1.22–1.51) | < 0.001 |
Calcium channel blocker | 1.59 (1.44–1.75) | < 0.001 |
Insulin | 0.56 (0.45–0.70) | < 0.001 |
NSAIDs | 0.90 (0.82–0.98) | 0.018 |
Diuretics | 0.82 (0.65–1.04) | 0.101 |
Oral steroids | 1.75 (1.56–1.96) | < 0.001 |
Intravenous steroids | 4.29 (3.82–4.81) | < 0.001 |